Cresco Labs (CRLBF) Change in Inventory (2020 - 2026)
Cresco Labs (CRLBF) posted Change in Inventory of -$7.6 million for Q1 2026, down 123.81% on a QoQ basis from $31.9 million in Q4 2025, and down 82.53% year-over-year from -$43.5 million in Q1 2025.
Cresco Labs (CRLBF) Change in Inventory (2020 - 2026) Analysis & Trends
Cresco Labs' Change in Inventory history runs 7 years deep, the most recent figure standing at -$7.6 million for Q1 2026.
- Quarterly Change in Inventory fell 82.53% year-over-year to -$7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 million (up 157.34% YoY) and the FY2025 annual result came in at $18.0 million, up 197.03% from the prior year.
- Change in Inventory was -$7.6 million for Q1 2026 at Cresco Labs, down from $31.9 million in the prior quarter.
- Across five years, Change in Inventory topped out at $31.9 million in Q4 2025 and bottomed at -$38.5 million in Q4 2023.
- A 5-year average of -$2.0 million and a median of $297000.0 in 2023 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 41972.41% in 2023, while the deepest fall reached 422.43% in 2023.
- Cresco Labs' Change in Inventory stood at $11.9 million in 2022, then tumbled by 422.43% to -$38.5 million in 2023, then climbed by 28.08% to -$27.7 million in 2024, then soared by 215.34% to $31.9 million in 2025, then slumped by 123.81% to -$7.6 million in 2026.
- Business Quant data shows CRLBF's Change in Inventory at -$7.6 million in Q1 2026, $31.9 million in Q4 2025, and -$4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.60 Mn |
| Mar 31, 2026 | -7.60 Mn |
| Dec 31, 2025 | 31.94 Mn |
| Dec 31, 2025 | 31.94 Mn |
| Sep 30, 2025 | -4.14 Mn |
| Sep 30, 2025 | -4.14 Mn |
| Jun 30, 2025 | -5.63 Mn |
| Jun 30, 2025 | -5.63 Mn |
| Mar 31, 2025 | -4.17 Mn |
| Mar 31, 2025 | -4.17 Mn |
| Dec 31, 2024 | -27.69 Mn |
| Dec 31, 2024 | -27.69 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | -38.50 Mn |
| Dec 31, 2023 | -38.50 Mn |